A review on chitosan and its development as pulmonary particulate anti-infective and anti-cancer drug carriers
RM Rasul, MT Muniandy, Z Zakaria, K Shah… - Carbohydrate …, 2020 - Elsevier
Chitosan, as a biodegradable and biocompatible polymer, is characterized by anti-microbial
and anti-cancer properties. It lately has received a widespread interest for use as the …
and anti-cancer properties. It lately has received a widespread interest for use as the …
Pulmonary drug delivery systems for tuberculosis treatment
Tuberculosis (TB) remains a major global health problem as it is the second leading cause
of death from an infectious disease worldwide, after the human immunodeficiency virus …
of death from an infectious disease worldwide, after the human immunodeficiency virus …
Inhaled drug therapy for treatment of tuberculosis
The lungs have received attention as a portal for drug delivery in tuberculosis (TB) from
researchers addressing diverse objectives. These include:(a) targeting alveolar …
researchers addressing diverse objectives. These include:(a) targeting alveolar …
Rifabutin loaded inhalable β-glucan microparticle based drug delivery system for pulmonary TB
Inhalable microparticle-based anti TB drug delivery systems are being investigated
extensively for Tuberculosis [TB] treatment as they offer efficient and deep lung deposition …
extensively for Tuberculosis [TB] treatment as they offer efficient and deep lung deposition …
Dry powder inhalers of antitubercular drugs
Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a
major health problem globally. Patients do not widely accept the conventional approach to …
major health problem globally. Patients do not widely accept the conventional approach to …
Dry powder inhalable formulations for anti-tubercular therapy
Tuberculosis (TB) is an intracellular infectious disease caused by the airborne bacterium,
Mycobacterium tuberculosis. Despite considerable research efforts, the treatment of TB …
Mycobacterium tuberculosis. Despite considerable research efforts, the treatment of TB …
Inhaled drug treatment for tuberculosis: Past progress and future prospects
AJ Hickey, PG Durham, A Dharmadhikari… - Journal of Controlled …, 2016 - Elsevier
Since the 1990s the rising incidence of multiple drug resistant TB, particularly in the context
of human immunodeficiency virus co-infected patients, has threatened global TB control. At …
of human immunodeficiency virus co-infected patients, has threatened global TB control. At …
Critical physicochemical and biological attributes of nanoemulsions for pulmonary delivery of rifampicin by nebulization technique in tuberculosis treatment
The study investigated aerosolization, pulmonary inhalation, intracellular trafficking potential
in macrophages and pharmacokinetics profiles of rifampicin-oleic acid first-generation …
in macrophages and pharmacokinetics profiles of rifampicin-oleic acid first-generation …
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics
Treatment for tuberculosis (TB) using the standard oral antibiotic regimen is effective but
inefficient, requiring high drug dosing and lengthy treatment times. Three concurrent first-line …
inefficient, requiring high drug dosing and lengthy treatment times. Three concurrent first-line …
[HTML][HTML] Preparation and characterization of beta-glucan particles containing a payload of nanoembedded rifabutin for enhanced targeted delivery to macrophages
Abstract β-glucan particles (GP) are polymeric carbohydrates, mainly found as components
of cell wall fungi, yeast, bacteria and also in cereals such as barley and oat, and have been …
of cell wall fungi, yeast, bacteria and also in cereals such as barley and oat, and have been …